The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer’s disease and mild cognitive impairment

Abstract

BACKGROUND Metabolomic processes have been identified as being strongly linked to the development of Alzheimer's disease (AD). Thus, lipid metabolites appear to be highly useful as diagnostic substrates for the diagnosis of AD and mild cognitive impairment (MCI) in plasma. METHODS We analyzed plasma samples from controls (n = 35), MCI (n = 33), and AD… (More)

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Klavins2015TheRO, title={The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer’s disease and mild cognitive impairment}, author={Kristaps Klavins and Therese Koal and Guido Dallmann and Josef Marksteiner and Georg Kemmler and Christian Humpel}, booktitle={Alzheimer's & dementia}, year={2015} }